Skip to Main Content

INFORMATION FOR

    Child Development & Autism | Genetics - Adult | Genetics - Pediatric | Mental Health & Behavioral Research, Phase Pilot

    Pivotal Response Treatment for Children With Autism Spectrum Disorders (PRT)

    What is the purpose of this trial?

    The purpose of this study is to evaluate the application of an evidence-based, manualized treatment for children with ASD (Pivotal Response Treatment, PRT) to children ages four through six years of age with ASD. Specifically, children will be randomly assigned to receive either (1) 10 hours per week of intervention services, including two hours per week of parent education, and eight hours per week of direct clinician-delivered services, or (2) a treatment as usual control. Intervention will focus on enhancing the following developmental skills: expressive and receptive language, play, and social interaction. Outcome measures will address changes in the aforementioned domains during structured observation and standardized assessment.

    • Trial with
      Yale University School of Medicine and National Institute of Neurological Disorders and Stroke (NINDS)
    • Ages
      4 years - 35 years
    • Gender
      Both

    Contact Information

    For more information about this study, including how to volunteer, contact Sukhodolsky Lab

    Help Us Discover!

    You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

    • Last Updated
      07/23/2024
    • Study HIC
      #1106008625